Product Brief 600V CoolSiC™ Schottky Diodes Generation 3

Product Brief
Third Generation thinQ!™
Silicon Carbide Schottky Diodes
Making Improved Efficiency now More Affordable
The new third generation of Infineon SiC Schottky diodes features the industry’s
lowest device capacitance for any given current rating, which further enhances
overall system efficiency, especially at higher switching frequencies and under
low load conditions. Together with the third generation, Infineon adds a new
package to the already available TO-220 and D2PAK: the DPAK. The small form
factor of the DPAK makes it particularly interesting for high power density
surface mount designs, and its introduction further extends the Infineon offer
of products in order to account at best for the different customer needs.
Features
„„
Lowest switching losses due to
lowest Qc for any current rating in
the market
„„
Fully surge-current stable,
high reliability and ruggedness
„„
Lower cost
Benefits
„„
System efficiency improvements
at light & medium load
„„
Enabling higher frequency designs
and increased power density
solutions
„„
Lower system costs due to reduced
cooling requirements
„„
Broadest range of current ratings
and lower costs/Amp. for
cost-effective performance
improvements
FSW = 130kHz
1.6
Diode losses of output power [%]
1.4
1.2
1.0
Applications
0.8
0.6
thinQ!TM3G 8A
thinQ!TM2G 8A
Competitor SiC diode 8A
Si Tandem diode 8A
0.4
0.2
0
0
200
Diode losses
Diode of
losses
output
of power
output power
[%]
[%]
1.6
1.4
1.6
1.2
1.4
1.0
1.2
0.8
1.0
0.6
0.8
0.4
0.6
0.2
0.4
0
0.2 0
0
0
400
600
800
Output power [W]
FSW = 130kHz
FSW = 250kHz
200
400
200
400
thinQ!TM3G 8A
thinQ!TM2G 8A
TM
Competitor
thinQ!
3G 8ASiC diode 8A
TM
Si Tandem
diode 8A
2G 8A
thinQ!
Competitor SiC diode 8A
600
800
Output power [W]
600
800
Output power [W]
www.infineon.com/sic
F = 250kHz
1.6
]
1.4
1000
SW
1000
1000
„„
SMPS e.g. CCM PFC
„„
LCD, PDP
„„
Lighting
„„
UPS, Solar applications
„„
Motor Drives
Product Brief
Third Generation thinQ!™
Silicon Carbide Schottky Diodes
Product Portfolio
Voltage
IF [A]
QC (typ.) [nC]
IF.SM [A]
Type
3
3.2
11.5
IDD03SG60C
4
4.5
18.0
IDD04SG60C
5
6.0
26.0
IDD05SG60C
6
8.0
32.0
IDD06SG60C
8
12.0
42.0
IDD08SG60C
9
15.0
49.0
IDD09SG60C
10
16.0
51.0
IDD10SG60C
12
19.0
59.0
IDD12SG60C
IF [A]
QC (typ.) [nC]
IF.SM [A]
Type
3
3.2
11.5
IDH03SG60C
TO-252
DPAK
600V
Voltage
TO-220
real2pin
600V
Published by
Infineon Technologies Austria AG
9500 Villach, Austria
© 2011 Infineon Technologies AG.
All Rights Reserved.
Visit us:
www.infineon.com
Order Number: B152-H9356-G2-X-7600-DB2011-0018
Date: 11 / 2011
4
4.5
18.0
IDH04SG60C
5
6.0
26.0
IDH05SG60C
6
8.0
32.0
IDH06SG60C
8
12.0
42.0
IDH08SG60C
9
15.0
49.0
IDH09SG60C
10
16.0
51.0
IDH10SG60C
12
19.0
59.0
IDH12SG60C
Attention please!
The information given in this document shall in no event
be regarded as a guarantee of conditions or characteristics
(“Beschaffenheitsgarantie”). With respect to any examples
or hints given herein, any typical values stated herein and/
or any information regarding the application of the device,
Infineon Technologies hereby disclaims any and all warranties and liabilities of any kind, including without limitation warranties of non-infringement of intellectual property
rights of any third party.
Information
For further information on technology, delivery terms and
conditions and prices please contact your nearest Infineon
Technologies Office (www.infineon.com).
Status
in production
Status
in production
Warnings
Due to technical requirements components may contain
dangerous substances. For information on the types in
question please contact your nearest Infineon Technologies
Office. Infineon Technologies Components may only be
used in life-support devices or systems with the express
written approval of Infineon Technologies, if a failure of
such components can reasonably be expected to cause
the failure of that life-support device or system, or to affect
the safety or effectiveness of that device or system. Life
support devices or systems are intended to be implanted
in the human body, or to support and/or maintain and
sustain and/or protect human life. If they fail, it is reasonable to assume that the health of the user or other persons
may be endangered.